Eagle Pharmaceuticals
EGRX
#11130
Rank
C$4.71 M
Marketcap
C$0.36
Share price
0.00%
Change (1 day)
-79.51%
Change (1 year)

EPS for Eagle Pharmaceuticals (EGRX)

EPS in 2023 (TTM): C$1.59

According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C$1.71. In 2022 the company made an earnings per share (EPS) of C$4.43 an increase over its 2021 EPS that were of C-$0.95.

EPS history for Eagle Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$1.59-63.99%
2022C$4.43-568.18%
2021C-$0.95
2019C$1.48-52.75%
2018C$3.12-36.63%
2017C$4.93-35.09%
2016C$7.591792.86%
2015C$0.40-117.39%
2014C-$2.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57 461.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52 341.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$44.26 2,495.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.90 1,360.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48 279.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.12 141.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.64-62.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel